200 related articles for article (PubMed ID: 27381686)
1. Antibody-targeted nanoparticles for cancer treatment.
Carter T; Mulholland P; Chester K
Immunotherapy; 2016 Jul; 8(8):941-58. PubMed ID: 27381686
[TBL] [Abstract][Full Text] [Related]
2. Aptamers and their applications in nanomedicine.
Sun H; Zu Y
Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
[TBL] [Abstract][Full Text] [Related]
3. Aptamers in targeted nanotherapy.
Mathew A; Maekawa T; Sakthikumar D
Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
6. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F; Yu M; Wang J; Tan F; Li N
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
[TBL] [Abstract][Full Text] [Related]
7. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
Guan B; Zhang X
Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
[TBL] [Abstract][Full Text] [Related]
8. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
10. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics.
Du W; Yuan Y; Wang L; Cui Y; Wang H; Xu H; Liang G
Bioconjug Chem; 2015 Dec; 26(12):2571-8. PubMed ID: 26580576
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
13. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
14. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.
Hosseini M; Haji-Fatahaliha M; Jadidi-Niaragh F; Majidi J; Yousefi M
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1051-61. PubMed ID: 25612903
[TBL] [Abstract][Full Text] [Related]
15. [Supramolecular Agents for Theranostics].
Deyev SM; Lebedenko EN
Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
[TBL] [Abstract][Full Text] [Related]
16. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.
Zhang P; Chen H; Liu J; Liu G
Methods Mol Biol; 2019; 2054():283-294. PubMed ID: 31482462
[TBL] [Abstract][Full Text] [Related]
17. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
19. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
20. Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging.
Yu J; Yin W; Zheng X; Tian G; Zhang X; Bao T; Dong X; Wang Z; Gu Z; Ma X; Zhao Y
Theranostics; 2015; 5(9):931-45. PubMed ID: 26155310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
